These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29098623)

  • 21. Cholesterol induces cardiac hypertrophy by activating the AKT pathway.
    Lee H; Yoo YS; Lee D; Song EJ
    J Steroid Biochem Mol Biol; 2013 Nov; 138():307-13. PubMed ID: 23907017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway.
    Shiojima I; Walsh K
    Genes Dev; 2006 Dec; 20(24):3347-65. PubMed ID: 17182864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy.
    McMullen JR; Shioi T; Zhang L; Tarnavski O; Sherwood MC; Kang PM; Izumo S
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12355-60. PubMed ID: 14507992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
    Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
    Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein kinase cascades in the regulation of cardiac hypertrophy.
    Dorn GW; Force T
    J Clin Invest; 2005 Mar; 115(3):527-37. PubMed ID: 15765134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiological myocardial hypertrophy: how and why?
    Catalucci D; Latronico MV; Ellingsen O; Condorelli G
    Front Biosci; 2008 Jan; 13():312-24. PubMed ID: 17981549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CpG-ODN attenuates pathological cardiac hypertrophy and heart failure by activation of PI3Kα-Akt signaling.
    Yang L; Cai X; Liu J; Jia Z; Jiao J; Zhang J; Li C; Li J; Tang XD
    PLoS One; 2013; 8(4):e62373. PubMed ID: 23638055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy.
    Luo J; McMullen JR; Sobkiw CL; Zhang L; Dorfman AL; Sherwood MC; Logsdon MN; Horner JW; DePinho RA; Izumo S; Cantley LC
    Mol Cell Biol; 2005 Nov; 25(21):9491-502. PubMed ID: 16227599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The biochemical response of the heart to hypertension and exercise.
    Wakatsuki T; Schlessinger J; Elson EL
    Trends Biochem Sci; 2004 Nov; 29(11):609-17. PubMed ID: 15501680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exercise training and PI3Kα-induced electrical remodeling is independent of cellular hypertrophy and Akt signaling.
    Yang KC; Tseng YT; Nerbonne JM
    J Mol Cell Cardiol; 2012 Oct; 53(4):532-41. PubMed ID: 22824041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphoinositide 3-kinase Akt signaling pathway interacts with protein kinase Cbeta2 in the regulation of physiologic developmental hypertrophy and heart function.
    Rigor DL; Bodyak N; Bae S; Choi JH; Zhang L; Ter-Ovanesyan D; He Z; McMullen JR; Shioi T; Izumo S; King GL; Kang PM
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H566-72. PubMed ID: 19122165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure.
    Aoyagi T; Matsui T
    Curr Pharm Des; 2011; 17(18):1818-24. PubMed ID: 21631421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic Akt blockade aggravates pathological hypertrophy and inhibits physiological hypertrophy.
    Buss SJ; Riffel JH; Malekar P; Hagenmueller M; Asel C; Zhang M; Weiss C; Katus HA; Hardt SE
    Am J Physiol Heart Circ Physiol; 2012 Jan; 302(2):H420-30. PubMed ID: 22058151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin signaling: a possible pathogenesis of cardiac hypertrophy.
    Yu W; Chen C; Fu Y; Wang X; Wang W
    Cardiovasc Ther; 2010 Apr; 28(2):101-5. PubMed ID: 20398099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. H-Ras Isoform Mediates Protection Against Pressure Overload-Induced Cardiac Dysfunction in Part Through Activation of AKT.
    Matsuda T; Jeong JI; Ikeda S; Yamamoto T; Gao S; Babu GJ; Zhai P; Del Re DP
    Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28193718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A dynamical system for the IGF1-AKT signaling pathway in skeletal muscle adaptation.
    Villota-Narvaez Y; Garzon-Alvarado DA; Ramirez-Martinez AM
    Biosystems; 2021 Apr; 202():104355. PubMed ID: 33453318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
    Glass DJ
    Curr Top Microbiol Immunol; 2010; 346():267-78. PubMed ID: 20593312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exercise training enhances cardiac IGFI-R/PI3K/Akt and Bcl-2 family associated pro-survival pathways in streptozotocin-induced diabetic rats.
    Cheng SM; Ho TJ; Yang AL; Chen IJ; Kao CL; Wu FN; Lin JA; Kuo CH; Ou HC; Huang CY; Lee SD
    Int J Cardiol; 2013 Jul; 167(2):478-85. PubMed ID: 22341695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFkappaB activation in vivo.
    Ha T; Li Y; Gao X; McMullen JR; Shioi T; Izumo S; Kelley JL; Zhao A; Haddad GE; Williams DL; Browder IW; Kao RL; Li C
    Free Radic Biol Med; 2005 Dec; 39(12):1570-80. PubMed ID: 16298682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway.
    McMullen JR; Shioi T; Huang WY; Zhang L; Tarnavski O; Bisping E; Schinke M; Kong S; Sherwood MC; Brown J; Riggi L; Kang PM; Izumo S
    J Biol Chem; 2004 Feb; 279(6):4782-93. PubMed ID: 14597618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.